Otsuka Pharma

Otsuka Pharma Scandinavia AB was founded in Stockholm in October 2001 aiming for the Scandinavian market. The company is part of the Otsuka Pharmaceutical Group. The European headquarters of Otsuka Pharmaceutical Europe Ltd. is located in London. Otsuka Pharmaceutical Co. Ltd., is one of the largest healthcare companies in Japan, lead by the group Otsuka Pharmaceutical.

In the Nordic and Baltic countries are a group of 16 people focused on the launch of a new drug for the treatment of intermittent claudication (Intermittent claudication) and further commercialization. Surrounding this condition has KeepWalking and Otsuka Pharma found a co. The recommendations regarding the treatment of Intermittent claudication as prescribed walking as the most effective treatment.

Within health care, it is fundamental to work with scientifically validated pedometers and whereas KeepWalking today has the pedometers which scientists recommend and use.

To Otsuka Pharma